1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Rituximab in Membranous Nephropathy
- 2020
- Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
- Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
- Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
- 2018
- Manifest för lämplig styrning av hälso- och sjukvården
- 2017
- Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
- Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis
- 2015
- Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis.
-
Slutreplik, Diana Karpman och medförfattare : - NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
Karpman, Diana LU
; Fehrman-Ekholm, Ingela
; Bárány, Peter
; Békássy, Zivile
LU
; Brandström, Per
; Bruchfeld, Annette
; Celsi, Gianni
; Chromek, Milan
LU
; Clyne, Naomi
LU
and Fellström, Bengt
, et al.
(2015)
In Läkartidningen
112.
Mark
-
NT-rådets ställningstagande till eculizumab är oacceptabelt
Karpman, Diana LU
; Fehrman-Ekholm, Ingela
; Bárány, Peter
; Békássy, Zivile
LU
; Brandström, Per
; Bruchfeld, Annette
; Celsi, Gianni
; Chromek, Milan
LU
; Clyne, Naomi
LU
and Fellström, Bengt
, et al.
(2015)
In Läkartidningen
112.
Mark